Materials Advances,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Superparamagnetic
iron
oxide
nanoparticles
with
enhanced
magnetic
properties
were
produced
by
combining
a
chemical
process
and
heat
treatment,
resulting
in
improved
heating
effects
reduced
cancer
cell
survival
during
hyperthermia
assays.
ACS Materials Au,
Год журнала:
2023,
Номер
3(6), С. 600 - 619
Опубликована: Авг. 21, 2023
Over
the
past
decade,
therapeutic
potential
of
nanomaterials
as
novel
drug
delivery
systems
complementing
conventional
pharmacology
has
been
widely
acknowledged.
Among
these
nanomaterials,
lipid-based
nanoparticles
(LNPs)
have
shown
remarkable
pharmacological
performance
and
promising
outcomes,
thus
gaining
substantial
interest
in
preclinical
clinical
research.
In
this
review,
we
introduce
main
types
LNPs
used
formulations
such
liposomes,
nanoemulsions,
solid
lipid
nanoparticles,
nanostructured
carriers,
polymer
hybrid
focusing
on
their
physicochemical
properties
potential.
We
discuss
computational
studies
modeling
techniques
to
enhance
understanding
how
interact
with
cargo
predict
effectiveness
interactions
applications.
also
analyze
benefits
drawbacks
various
LNP
production
nanoprecipitation,
emulsification,
evaporation,
thin
film
hydration,
microfluidic-based
methods,
an
impingement
jet
mixer.
Additionally,
major
challenges
associated
industrial
development,
including
stability
sterilization,
storage,
regulatory
compliance,
reproducibility,
quality
control.
Overcoming
facilitating
compliance
represent
key
steps
toward
LNP's
successful
commercialization
translation
into
settings.
Pharmaceutical Development and Technology,
Год журнала:
2022,
Номер
27(5), С. 525 - 544
Опубликована: Май 28, 2022
The
bioavailability
of
drugs
is
dependent
on
several
factors
such
as
solubility
and
the
administration
route.
A
drug
with
poor
aqueous
solubility,
therefore,
poses
challenges
regards
to
its
pharmaceutical
advance
ultimately
biological
usage.
Lipid
nanoparticles
have
been
used
in
science
due
their
importance
green
chemistry.
Their
biochemical
properties
‘green’
materials
processes
mean
they
can
be
environmentally
sustainable.
Generally,
lipid
employed
carriers
for
both
lipophilic
hydrophilic
drugs.
proposed
route
present
advantages
disadvantages
which
should
considered
by
a
formulator.
Solid
(SLNs)
nanostructured
(NLCs)
are
attractive
delivery
systems
because
ease
manufacture,
biocompatibility,
biodegradability,
scale-up
capacity
formulation
constituents.
easy
simple
scalability
novel
SLNs
nano
carriers,
along
various
processing
procedures,
recent
developments,
limitation
toxicity,
optimization
approaches
manufacture
nanoparticles,
lyophilization
release
comprehensively
discussed
this
review.
This
review
also
summarizes
research
data
related
preparation
methods
excipients
NLCs
years.
Pharmaceutics,
Год журнала:
2023,
Номер
15(2), С. 656 - 656
Опубликована: Фев. 15, 2023
Skin
delivery
is
an
exciting
and
challenging
field.
It
a
promising
approach
for
effective
drug
due
to
its
ease
of
administration,
handling,
high
flexibility,
controlled
release,
prolonged
therapeutic
effect,
adaptability,
many
other
advantages.
The
main
associated
challenge,
however,
low
skin
permeability.
healthy
barrier
that
serves
as
the
body's
primary
defence
mechanism
against
foreign
particles.
New
advances
in
(both
topical
transdermal)
depend
on
overcoming
challenges
with
molecule
permeation
irritation.
These
limitations
can
be
overcome
by
employing
new
approaches
such
lipid
nanosystems.
Due
their
advantages
(such
easy
scaling,
cost,
remarkable
stability)
these
systems
have
attracted
interest
from
scientific
community.
However,
successful
formulation,
several
factors
including
particle
size,
surface
charge,
components,
etc.
understood
controlled.
This
review
provided
brief
overview
structure
well
different
pathways
nanoparticle
penetration.
In
addition,
influencing
penetration
nanoparticles
been
highlighted.
Applications
nanosystems
dermal
transdermal
delivery,
regulatory
aspects,
were
critically
discussed.
Biomedicines,
Год журнала:
2022,
Номер
10(9), С. 2179 - 2179
Опубликована: Сен. 2, 2022
Lipid
nanoparticles
(LNPs)
have
emerged
as
a
powerful
non-viral
carrier
for
drug
delivery.
With
the
prevalence
of
respiratory
diseases,
particularly
highlighted
by
current
COVID-19
pandemic,
investigations
into
applying
LNPs
to
deliver
inhaled
therapeutics
directly
lungs
are
underway.
The
progress
in
LNP
development
well
recent
pre-clinical
studies
three
main
classes
encapsulated
drugs:
small
molecules,
nucleic
acids
and
proteins/peptides
will
be
discussed.
advantages
pulmonary
delivery
system
such
reducing
systemic
toxicity
enabling
higher
local
concentration
evaluated
together
with
challenges
design
considerations
improved
formulations.
This
review
provides
perspective
on
future
prospects
LNP-mediated
diseases.
Abstract
The
protein
corona
forms
spontaneously
on
nanoparticle
surfaces
when
nanomaterials
are
introduced
into
any
biological
system/fluid.
Reliable
characterization
of
the
is,
therefore,
a
vital
step
in
development
safe
and
efficient
diagnostic
therapeutic
nanomedicine
products.
2134
published
manuscripts
reviewed
down‐selection
470
papers
spanning
2000–2021,
comprising
1702
(NP)
systems
is
analyzed.
This
analysis
reveals:
i)
most
studies
have
been
conducted
metal
oxide
nanoparticles;
ii)
despite
their
overwhelming
presence
clinical
practice,
lipid‐based
NPs
underrepresented
research,
iii)
use
new
methods
to
improve
reliability
reproducibility
research;
iv)
more
specific
sources
toward
personalized
medicine;
v)
careful
nanoparticles
after
formation
imperative
minimize
role
aggregation
contamination
outcomes.
As
used
biomedicine
become
increasingly
prevalent
biochemically
complex,
field
research
will
need
focus
developing
analytical
approaches
techniques
appropriate
for
each
unique
formulation.
Achieving
such
nano‐bio
interface
nanobiotechnologies
enable
seamless
implementation
medicine.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(21), С. 15764 - 15764
Опубликована: Окт. 30, 2023
Nano-range
bioactive
colloidal
carrier
systems
are
envisaged
to
overcome
the
challenges
associated
with
treatments
of
numerous
diseases.
Lipid
nanoparticles
(LNPs),
one
extensively
investigated
drug
delivery
systems,
not
only
improve
pharmacokinetic
parameters,
transportation,
and
chemical
stability
encapsulated
compounds
but
also
provide
efficient
targeting
reduce
risk
toxicity.
Over
last
decades,
nature-derived
polyphenols,
vitamins,
antioxidants,
dietary
supplements,
herbs
have
received
more
attention
due
their
remarkable
biological
pharmacological
health
medical
benefits.
However,
poor
aqueous
solubility,
compromised
stability,
insufficient
absorption,
accelerated
elimination
impede
research
in
nutraceutical
sector.
Owing
possibilities
offered
by
various
LNPs,
ability
accommodate
both
hydrophilic
hydrophobic
molecules
availability
preparation
methods
suitable
for
sensitive
molecules,
loading
natural
fragile
into
LNPs
offers
a
promising
solution.
The
primary
objective
this
work
is
explore
synergy
between
nature
nanotechnology,
encompassing
wide
range
aimed
at
encapsulating
therapeutic
within
LNPs.
Journal of Drug Delivery Science and Technology,
Год журнала:
2023,
Номер
86, С. 104709 - 104709
Опубликована: Июль 3, 2023
Solid
lipid
nanoparticles
(SLN)
are
considered
at
the
forefront
of
nanotechnology's
rapidly
developing
field,
with
several
potential
applications
in
drug
delivery
and
research.
SLN
possesses
promising
attributes
for
reaching
goal
controlled
site-specific
hence
attracted
researchers'
wide
attention.
The
present
review
briefly
introduces
discusses
reasoning
behind
use
over
other
colloidal
carriers,
such
as
emulsions
liposomes.
Techniques
to
produce
SLN,
incorporation,
loading
capacity,
release
mechanisms
reviewed.
Aspects
SLNs
route
administration
vivo
fate
carriers
also
discussed.
incorporating
different
anti-cancer
drugs
their
effectiveness
various
cancer
therapies
is
highlighted.
mechanism
action
some
commonly
used
agents
provided.